VKTX - Viking Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$93.60
DETAILS
HIGH:
$101.00
LOW:
$83.00
MEDIAN:
$95.00
CONSENSUS:
$93.60
UPSIDE:
140.86%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,676,713 | $54.6M | 0.0% | +1,538,313 | INCREASED |
| Greenblatt | 260,778 | $8.5M | 0.0% | +21,549 | INCREASED |
| Dalio | 71,229 | $2.3M | 0.0% | -32,430 | DECREASED |
| Wood | 19,000 | $618,260 | 0.0% | +12,100 | INCREASED |
| Soros | 0 | $0 | -- | -90,000 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-01 | Chen Hubert C | officer: Chief Medical Officer | A-Award | 190,000 | $31.27 | $5.9M |
| 2026-06-01 | Chen Hubert C | ? | -- | -- | -- | |
| 2026-03-10 | Aubuchon Neil William | officer: Chief Commercial Officer | BUY | 4,475 | $33.50 | $150K |
| 2026-01-12 | Aubuchon Neil William | ? | -- | -- | -- | |
| 2026-01-12 | Aubuchon Neil William | officer: Chief Commercial Officer | A-Award | 180,000 | $31.76 | $5.7M |
| 2026-01-02 | ZANTE GREG | officer: Chief Financial Officer | A-Award | 32,049 | -- | -- |
| 2026-01-02 | ZANTE GREG | officer: Chief Financial Officer | A-Award | 41,000 | -- | -- |
| 2026-01-05 | Mancini Marianna | officer: Chief Operating Officer | SELL | 31,961 | $32.29 | $1.0M |
| 2026-01-02 | Mancini Marianna | officer: Chief Operating Officer | A-Award | 41,000 | -- | -- |
| 2026-01-05 | Mancini Marianna | officer: Chief Operating Officer | SELL | 13,600 | $33.37 | $454K |
| 2026-01-05 | Mancini Marianna | officer: Chief Operating Officer | SELL | 10,500 | $34.22 | $359K |
| 2026-01-02 | Mancini Marianna | officer: Chief Operating Officer | A-Award | 91,000 | $35.42 | $3.2M |
| 2026-01-02 | Lian Brian | director, officer: President & CEO | A-Award | 224,080 | -- | -- |
| 2026-01-05 | Lian Brian | director, officer: President & CEO | SELL | 6,400 | $35.07 | $224K |
| 2026-01-02 | MACARTNEY LAWSON | director | A-Award | 3,150 | -- | -- |
| 2026-01-02 | MACARTNEY LAWSON | director | A-Award | 20,400 | $35.42 | $723K |
| 2026-01-02 | Rowland Charles A Jr | director | A-Award | 3,150 | -- | -- |
| 2026-01-02 | Rowland Charles A Jr | director | A-Award | 20,400 | $35.42 | $723K |
| 2026-01-02 | FOEHR MATTHEW W | director | A-Award | 20,400 | $35.42 | $723K |
| 2026-01-02 | FOEHR MATTHEW W | director | M-Exempt | 16,000 | $3.33 | $53K |
| 2026-01-02 | FOEHR MATTHEW W | director | SELL | 16,000 | $35.11 | $562K |
| 2026-01-02 | Lian Brian | director, officer: President & CEO | A-Award | 176,300 | $35.42 | $6.2M |
| 2026-01-02 | SINGLETON J MATTHEW | director | A-Award | 20,400 | $35.42 | $723K |
| 2026-01-05 | ZANTE GREG | officer: Chief Financial Officer | SELL | 1,500 | $32.09 | $48K |
| 2026-01-02 | ZANTE GREG | officer: Chief Financial Officer | A-Award | 91,000 | $35.42 | $3.2M |